SIGA News and Press, SIGA Technologies Inc. From 08/11/22

Palm Beach, FL –– August 11, 2022 – FinancialNewsMedia.com News Commentary – Multiple Sclerosis (MS) is an immune-mediated disease affecting the central nervous system. It is characterized by demyelination, inflammation, degenerative changes such as p...

According to the latest data compiled by the Centers for Disease Control and Prevention (CDC), the recent monkeypox outbreak has led to 10,392 cases as of Wednesday. The country has added 900 cases on Wednesday alone per the Our World in Data project, a public online data hub base...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Viacheslav Lopatin / Shutterstock.com SIGA Technologies (NASDAQ: SIGA ) stock is sliding on Wednesday as the pharmaceutical company trends on Google with recent monkeypox news. That drop is despite the...

SIGA Technologies Inc. (NASDAQ:SIGA) traded today at a new 52-week high of $24.42. Approximately 924,000 shares have changed hands today, as compared to an average 30-day volume of 15.3 million shares. SIGA Technologies Inc. (NASDAQ:SIGA) is currently priced 9.8% above its average consen...

SIGA Technologies ( NASDAQ: SIGA ) announced Tuesday that the company will deliver approximately $26M worth of treatment courses of its lead product TPOXX in 2023 after the U.S. government decided to exercise a procurement option. TPOXX, indicated in the U.S. for smallpox,...

- IV TPOXX is an Important Option for Those Unable to Swallow – - Option to Fund Post-Marketing Field Study for IV TPOXX also Exercised – NEW YORK, Aug. 09, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-st...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips There’s a lot going on with Siga Technologies  (NASDAQ: SIGA ) stock lately. First of all, Siga released its second-quarter 2022 financial results . The company also is in the spotlight after the World ...

SIGA Technologies, Inc. (SIGA) Q2 2022 Earnings Conference Call August 04, 2022, 16:30 ET Company Participants Phillip Gomez - CEO & Director Dennis Hruby - EVP & Chief Scientific Officer Daniel Luckshire - EVP, CFO & Secretary Conference Call P...

The biotech industry for the first half of the year had seen better six-month periods in the past, but the situation appears to have changed beginning in July. From Jan. 1 to June 20, 2022, the SPDR S&P Biotech ETF ( XBI ) and iShares Nasdaq Biotechnology ETF ( IBB ) had...

Tpoxx (tecovirimat), an antiviral medication from SIGA Technologies ( NASDAQ: SIGA ), will begin testing in humans as soon as September, Bloomberg reported. The drug is currently only approved for smallpox but is available as a treatment for smallpox under the U.S....